Prime Medicine Announces Strategic Restructuring to Focus
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as...
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as...
The investment required to meet the challenges of competitiveness and energy and technology transition in the European Union is huge,...
Let’s drop the polite fiction: AI is coming for your job. More accurately, it’s coming for your current job. This...
During her tenure, Ms Ryan led the organisation through major transformations, including renewing the Registered Training Organisation status, delivering a...
The charity sector is going through a lot of changes at the moment. This makes the role of an interim...
A new Scottish green finance initiative is underway, aiming to activate £40bn a year in investment for green energy projects...
Editor's Note: This analysis was originally published as a stock note by Morningstar Equity Research.Novo Nordisk CEO Lars Fruergaard Jørgensen...
Maximising Broker Growth with B2CORE’s IB Module Maximising Broker Growth with B2CORE’s IB Module Maximising Broker Growth with B2CORE’s IB...
Deriv has appointed Rakshit Choudhary as its new Chief Executive Officer, signaling a leadership evolution that places artificial intelligence at...